I haven't seen many leadership changes the market have liked, anywhere to be honest.
I don't believe it signals slowing growth, the USA results were relatively good in 1H23 and it seems the new product launches appear to be driving revenue growth and reduced EBITDA loss. I was a bit surprised as I thought Waltrip might survive as a result. However, IMO he has been a dead man walking for some time now, they were probably just looking for the right time to exit him.
- Forums
- ASX - By Stock
- A2M
- Ann: Leadership changes to USA, ANZ and MVM businesses
Ann: Leadership changes to USA, ANZ and MVM businesses, page-8
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.82 |
Change
-0.100(2.03%) |
Mkt cap ! $3.489B |
Open | High | Low | Value | Volume |
$4.95 | $4.95 | $4.77 | $31.51M | 6.542M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3831 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.82 | 252136 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3831 | 4.810 |
2 | 4260 | 4.800 |
2 | 6100 | 4.790 |
5 | 31763 | 4.780 |
4 | 29250 | 4.770 |
Price($) | Vol. | No. |
---|---|---|
4.820 | 252136 | 2 |
4.830 | 25742 | 4 |
4.840 | 5000 | 1 |
4.850 | 268495 | 4 |
4.860 | 118035 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online